CLOs on the Move

NewLeaf Symbiotics

NewLeaf Symbiotics is a science-based company doing cutting-edge research and product development, using a naturally occurring family of beneficial plant bacteria. Pink pigmented facultative methylotrophs (PPFMs) are broadly distributed throughout the natural world and improve access to several essential nutrients that all plants need to grow. Studies have shown that when PPFMs are added to seeds in a prescribed manner and concentration, the plants grow faster and with more vigor, are healthier, and generate higher yields.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million


Name Title Contact Details
Molly Edwards
General Counsel Profile

Similar Companies

Howell and Haferkamp

Howell & Haferkamp, L.C. is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Front Range Biosciences

Front Range Biosciences enables a grower to reduce crop loss due to pathogens, quickly sex a plant, and develop new strains of plants that have the most valuable commercial properties.

Alphora Research Inc

Alphora Research Inc is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Octave Bioscience

Octave is developing a comprehensive, first-in-class Care Management Platform.


Univercells is a technology company offering novel biomanufacturing platforms, aimed at increasing the availability and affordability of biologics – recombinant proteins and vaccines - for all. Univercells designs innovative production processes to significantly decrease the size of the necessary equipment and facility, for a lower capital and operational cost. The company`s process intensification and integration technology entails smaller footprint and unit cost while offering flexible capabilities, from small to large batches. Deployment of affordable production units enables `in-country, for-country` biologics production, creating value for manufacturers and healthcare systems with cost efficiency and local supply while increasing patients` access to healthcare. Univercells was founded in 2013 by experienced entrepreneurs Hugues Bultot, CEO, and José Castillo, CTO, who bring close to 25 years of expertise in the biotechnology and life sciences sectors. Headquartered in Gosselies (Belgium), Univercells benefits from support from the Walloon region, and received €3 million from Takeda in 2015. Most recently, the company was awarded a $12 million grant from the Bill & Melinda Gates Foundation.